欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号BE/V/0029/001
药品名称Linco-Spectin 100
活性成分
    • LINCOMYCIN hydrochloride 222.0 mg/g
    • SPECTINOMYCIN sulfate 444.7 mg/g
剂型Powder for use in drinking water
上市许可持有人Zoetis Belgium SA Rue Laid Burniat, 1 1348 Louvain-la-Neuve Belgium
参考成员国 - 产品名称Belgium (BE)
Linco-Spectin 100
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
      LINCO-SPECTIN 100
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
许可日期2014/07/24
最近更新日期2025/01/17
药物ATC编码
    • QJ01FF52 lincomycin, combinations
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase